Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Product Launch

23 Sep 2009 07:00

RNS Number : 4943Z
Imaginatik PLC
23 September 2009
 



23 September 2009

Imaginatik plc

("Imaginatik" or the "Company")

Launch of ChemBioConnect

CambridgeSoft and Imaginatik launch Visual Collaboration Tool for Scientists

Imaginatik plc (AIM: IMTK), a leading provider of enterprise collaboration software, announces the launch of ChemBioConnect, an online collaboration tool for use by researchers in the chemistry, biotechnology and pharmaceutical industries.

Developed in conjunction with CambridgeSoft, ChemBioConnect allows scientists to draw, view, edit, archive and search chemical structures and biological systems in a secure, robust collaboration and idea management environment. The resource effectively allows for collaborative problem-solving among scientists by combining CambridgeSoft's chemically intelligent visual toolsets with Imaginatik's research-based, enterprise-scale system, comprised of software, services and a deep understanding of how human networks operate. This offering is targeted to meet the needs of research and development professionals in the areas of pharmaceuticals, bioscience, biotechnology, chemistry and food science.

"Professional chemists think and communicate visually, whether doodling on paper, working in teams at a whiteboard, or keeping a notebook," said Dr. Robin Spencer, Senior Research Fellow at Pfizer, Inc. "At Pfizer we have seen that marrying the ability to work visually with a secure collaborative innovation environment like ChemBioConnect gives our scientists a scalable and secure new way to capture ideas and solve challenging problems."

"Collaboration is vital in all forms of business activity, and chemistry and biology are not exceptions to this rule," said Mark Turrell, CEO of Imaginatik. "ChemBioConnect is the first in a series of industry specific modules of our core collaboration software platform, Idea Central, which we intend to launch in the years ahead, supporting our growth and market leadership position." 

"We are pleased to be working together with Imaginatik," said Michael G. Tomasic, President and CEO of CambridgeSoft. "With this collaboration we are ensuring that our customers benefit from the integration of CambridgeSoft's leading chemical and biological drawing software, ChemBioDraw, with Imaginatik's innovation engine to drive collaborative problem solving for new research insights and higher efficiency."

ChemBioConnect is being sold by Imaginatik with support from CambridgeSoft.

For further information please contact:

Imaginatik plc

Tel: 020 7917 2975

Mark Turrell, CEO / Shawn Taylor, CFO

Arbuthnot Securities Limited

Tel: 020 7012 2000

Tom Griffiths

ICIS

Tel: 020 7651 8688

Caroline Evans-Jones / Hilary Millar

About Imaginatik

Imaginatik is the leading provider of Collective Intelligence solutions, including Collaborative Innovation, Open Innovation and Idea Management technology and services. Some of the leading companies in the world use Imaginatik's Idea Central software platform to identify and develop the important ideas and strategies that will drive the future of their business. For more than 10 years, Imaginatik has helped customers including CSC, Pfizer, Boeing, Chubb and Cargill achieve outstanding results with its highly configurable web-based software and experienced consulting team.

A World Economic Forum Technology Pioneer with offices in Boston, MA, and London, UK, Imaginatik is committed to ongoing research into the nature of human networks, innovation and collective problem solving. The company collaborates with several academic institutions including the IXL Center at Hult International Business School. Imaginatik is publicly traded on the London Stock Exchange [AIM:IMTK.L].

For further information please visit http://www.imaginatik.com

About CambridgeSoft

CambridgeSoft develops and markets life science enterprise solutions for pharmaceutical, biotechnology, chemical companies and scientific research organizations. Software products include enterprise, workgroup and desktop versions of Chem & Bio Office, including Chem & Bio Draw and E-Notebook, with knowledge management, chemical and biological informatics, and scientific database solutions. Web sites include ChemBioFinder.Com and ChemBioNews.Com for indexed database content and news, and SciStore.Com for e-commerce. CambridgeSoft has offices in the United StatesEurope and Asia Pacific. For more information, please go to www.cambridgesoft.com.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAPUUPPBUPBGQP
Date   Source Headline
19th Dec 20083:16 pmRNSDirector/PDMR Shareholding
18th Dec 20089:45 amRNSDirector/PDMR Shareholding
17th Dec 20087:00 amRNSShare Option Schemes
1st Dec 20087:00 amRNSDirector's Disclosure Update
19th Nov 200812:39 pmRNSDirectors Dealing
13th Nov 20087:00 amRNSInterim Results
14th Oct 20087:00 amRNSTrading Statement
2nd Oct 20087:00 amRNSContract Win
30th Sep 20084:30 pmRNSTotal Voting Rights
24th Sep 20087:00 amRNSDirector/PDMR Shareholding
15th Sep 20087:00 amRNSContract Win
3rd Sep 20087:00 amRNSIssue of Equity
21st Aug 20087:00 amRNSContract Win
28th Jul 20089:27 amRNSNon-Executive Retirement
10th Jul 200810:20 amRNSResult of AGM
10th Jul 20087:00 amRNSAGM Statement
24th Jun 20087:00 amRNSDirector/PDMR Shareholding
18th Jun 200810:05 amRNSAnnual Report and Accounts
13th Jun 200812:16 pmRNSDirector/PDMR Shareholding
11th Jun 20087:00 amRNSFinal Results
1st Apr 200811:52 amRNSDirector Dealings
31st Mar 20084:30 pmRNSTotal Voting Rights
17th Mar 20082:57 pmRNSShare Subscription - Update
10th Mar 20082:23 pmRNSShare Subscription
10th Mar 20089:30 amRNSHolding(s) in Company
28th Feb 200810:01 amRNSPfizer Update
13th Feb 20089:40 amRNSTrading Statement
22nd Jan 20089:30 amRNSWorld Economic Forum
11th Jan 200810:13 amRNSMajor Contract Wins
30th Nov 20072:41 pmRNSWEF Technology Pioneer
14th Nov 20072:12 pmRNSInterim Results
16th Aug 200711:05 amRNSAgreement With IBM
14th Aug 20074:55 pmRNSAIM Rule 26 Information
27th Jul 200710:46 amRNSAGM Statement
27th Jul 20077:01 amRNSAGM Statement
11th Jul 200712:00 pmBUSGlobal Competition Forces Innovation and Collaboration Acceleration
29th Jun 20073:33 pmRNSAnnual Report and Accounts
13th Jun 200711:50 amRNSResult of EGM
12th Jun 20077:02 amRNSFinal Results
4th Jun 20077:02 amRNSUK & European Contract Wins
1st Jun 200710:29 amRNSNotice of Results
18th May 200710:05 amRNSNotice of EGM
23rd Apr 20072:38 pmBUSImaginatik Wins a Queens Award for Enterprise
23rd Apr 200711:02 amRNSWins A Queens Award
19th Apr 200710:59 amRNSDirector/PDMR Shareholding
21st Mar 20077:04 amRNSSenior Management Appointment
21st Mar 20077:01 amBUSImaginatik Appoints President, Americas and New CMO to Accommodate Growth
16th Mar 200711:45 amRNSTrading Statement
9th Feb 200711:30 amBUSImaginatik Appoints Managing Director in United Kingdom
9th Feb 20077:00 amRNSAppointment of UK MD

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.